<DOC>
	<DOCNO>NCT02040532</DOCNO>
	<brief_summary>The broad goal study obtain pilot data determine tolerability preliminary efficacy non-hormonal agent gabapentin insomnia symptom nighttime vasomotor Symptoms ( VMS ) open-label gabapentin administer low dose night peri- postmenopausal woman . We hypothesize majority participant able increase tolerate treatment , insomnia symptom frequency nighttime VMS improve low-dose gabapentin dose bedtime .</brief_summary>
	<brief_title>Gabapentin Insomnia Symptoms Nighttime Vasomotor Symptoms ( VMS ) Peri- Postmenopausal Women</brief_title>
	<detailed_description>Thirty-two peri- postmenopausal woman Boston site ( MGH BWH ) enrol open-label pilot study . The study 7-week intervention study use open-label gabapentin bedtime schedule dose titration 100-mg one week , follow 300-mg 3 week , 600-mg 3 week . The intervention study follow 3-week screening period establish stable baseline insomnia symptom VMS determine safety administer gabapentin study participant . Tolerability treatment response ( insomnia symptom , nighttime VMS ) assess systematically study visit . The dose titration schedule follow participant unless dose-limiting toxicity .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Females age 4065 year 2 . Postmenopausal perimenopausal 3 . Having bothersome hot flash 4 . Having bothersome hot flash night 5 . Insomnia problem sleep 6 . In general , good health 7 . Signed informed consent 1 . Recent use hormone therapy hormonal contraceptive ( exception Mirena IUD ) 2 . Recent use prescribe therapy take specifically hot flash 3 . Recent use overthecounter herbal therapy take specifically hot flash 4 . Recent use prescribe medication know hot flash efficacy 5 . Known hypersensitivity contraindication ( reason take ) gabapentin 6 . Not use medically approve method birth control , sexually active 12 month since last menstrual period 7 . Recent drug alcohol abuse 8 . Lifetime diagnosis psychosis bipolar disorder 9 . Suicide attempt past 3 year current suicidal ideation 10 . Current major depression ( assessed screening ) 11 . Pregnancy , intend pregnancy , breast feeding 12 . History : 1 . Renal insufficiency kidney disorder 2 . Sleep disorder diagnosis sleep apnea , restless legs syndrome , periodic limb movement disorder , narcolepsy 13 . Any unstable medical condition 14 . Working night/rotating shift 15 . Abnormal screen blood test 16 . Current participation another drug trial intervention study 17 . Inability unwillingness complete study procedure</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>